Infected erythrocytes and plasma proteomics reveal a specific protein signature of severe malaria
-
Published:2024-01-31
Issue:2
Volume:16
Page:319-333
-
ISSN:1757-4684
-
Container-title:EMBO Molecular Medicine
-
language:en
-
Short-container-title:EMBO Mol Med
Author:
Fraering Jeremy, Salnot Virginie, Gautier Emilie-Fleur, Ezinmegnon Sem, Argy Nicolas, Peoc’h Katell, Manceau HanaORCID, Alao Jules, Guillonneau FrançoisORCID, Migot-Nabias FlorenceORCID, Bertin Gwladys IORCID, Kamaliddin ClaireORCID, , Aubouy Agnes, Affolabi Dissou, Biokou Bibiane, Cot Michel, Degbelo Jean-Eudes, Deloron Philippe, Dramane Latifou, Faucher Jean-François, Guillochon Emilie, Houze Ludivine, Jafari-Guemouri Sayeh, Houze Sandrine, Joste Valentin, Labrunie Anaïs, Ladipo Yélé, Lathiere Thomas, Massougbodji Achille, Mowendabeka Audrey, Papin Jade, Pipy Bernard, Preux Pierre-Marie, Raymondeau Marie, Royo Jade, Sossou Darius, Techer Brigitte, Vianou Bertin
Abstract
AbstractCerebral malaria (CM), the most lethal complication of Plasmodium falciparum severe malaria (SM), remains fatal for 15–25% of affected children despite the availability of treatment. P. falciparum infects and multiplies in erythrocytes, contributing to anemia, parasite sequestration, and inflammation. An unbiased proteomic assessment of infected erythrocytes and plasma samples from 24 Beninese children was performed to study the complex mechanisms underlying CM. A significant down-regulation of proteins from the ubiquitin–proteasome pathway and an up-regulation of the erythroid precursor marker transferrin receptor protein 1 (TFRC) were associated with infected erythrocytes from CM patients. At the plasma level, the samples clustered according to clinical presentation. Significantly, increased levels of the 20S proteasome components were associated with SM. Targeted quantification assays confirmed these findings on a larger cohort (n = 340). These findings suggest that parasites causing CM preferentially infect reticulocytes or erythroblasts and alter their maturation. Importantly, the host plasma proteome serves as a specific signature of SM and presents a remarkable opportunity for developing innovative diagnostic and prognostic biomarkers.
Funder
Merieux Agence Nationale de la Recherche French Minister of Research
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. Aguilar R, Moraleda C, Achtman AH, Mayor A, Quintó L, Cisteró P, Nhabomba A, Macete E, Schofield L, Alonso PL et al (2014) Severity of anaemia is associated with bone marrow haemozoin in children exposed to Plasmodium falciparum. Br J Haematol 164:877–887 2. Alvarez-Jarreta J, Amos B, Aurrecoechea C, Bah S, Barba M, Barreto A, Basenko EY, Belnap R, Blevins A, Böhme U et al (2023) VEuPathDB: the eukaryotic pathogen, vector and host bioinformatics resource center in 2023. Nucleic Acids Res 11:gkad1003 3. Andrade CM, Fleckenstein H, Thomson-Luque R, Doumbo S, Lima NF, Anderson C, Hibbert J, Hopp CS, Tran TM, Li S et al (2020) Increased circulation time of Plasmodium falciparum underlies persistent asymptomatic infection in the dry season. Nat Med 26:1929–1940 4. Aschemeyer S, Qiao B, Stefanova D, Valore EV, Sek AC, Ruwe TA, Vieth KR, Jung G, Casu C, Rivella S et al (2018) Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood 131:899–910 5. Bahl A, Brunk B, Crabtree J, Fraunholz MJ, Gajria B, Grant GR, Ginsburg H, Gupta D, Kissinger JC, Labo P et al (2003) PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res 31:212–215
|
|